ArticleCell communication and signaling : CCS2026
Hormone-sensitive lipase drives pro-resolving macrophage polarization and enhances efferocytosis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Fatty acid metabolism and lipid channeling in macrophages: mechanisms of inflammation, resolution, and lipotoxicity.Frontiers in immunology · 2026Review
- Neutrophil-macrophage crosstalk network in acute lung injury: feedback circuits linking cytokine storm and cell death.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLipid droplets (LDs) are vital organelles in cellular energy regulation, controlling lipid storage and mobilization. However, their specific roles in macrophage function, particularly in the context of immune regulation, remain elusive. This study aimed to elucidate how LD manipulation affects macrophage phenotypes and functions, with a focus on their role in efferocytosis and inflammatory modulation. We also explored the novel function of hormone-sensitive lipase (HSL) in regulating LD metabolism and macrophage polarization.
methodsHuman monocytes were differentiated into M1 (IFN-γ/LPS) or M2 (IL-4) macrophages. To determine the functional role of HSL, we employed pharmacological inhibition, siRNA-mediated knockdown, and plasmid-driven overexpression. Phenotypic and functional effects on efferocytosis, gene expression, and cytokine secretion were evaluated using flow cytometry, qRT-PCR, and ELISA. The underlying mechanisms were explored through unbiased quantitative lipidomics, real-time metabolic flux analysis to assess mitochondrial respiration, and high-resolution imaging via confocal and electron microscopy, which confirmed alterations in the LD dynamics.
resultsM2 macrophages exhibited increased efferocytosis and contained smaller, more numerous lipid droplets with greater lipase activity compared to M1 macrophages. Inhibition or siRNA-mediated knockdown of HSL reduced efferocytosis and downregulated the expression of M2 markers, including CD206, CD163, CD200R1, and Annexin A1, while promoting a pro-inflammatory state. Conversely, HSL overexpression in naive macrophages induced a strong M2-like phenotype, characterized by increased efferocytosis and elevated mitochondrial respiration. We highlighted the key role of the cAMP-protein kinase A pathway in promoting lipolysis of LD via HSL activation. Lipidomic analysis revealed distinct lipid profiles for M1 and M2 macrophages, as well as for M2 macrophages with HSL inhibition. Lipidomic results indicated that M2 macrophages contain specific monounsaturated fatty acids, such as Nervonic Acid (FA 24:1), which can enhance efferocytosis by M1 macrophages.
conclusionsThis study identifies a novel mechanism by which LD lipolysis, mediated by HSL, promotes M2 macrophage polarization and enhances efferocytosis. These findings highlight the importance of LD metabolism in macrophage function and suggest HSL as a potential therapeutic target for immune-mediated conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.